ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
Promotion
Recombinantタンパク質s ClearClear history
Recombinantタンパク質s CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > IgG1

IgG1

概要

Name:Immunoglobulin G
Target Synonym:Immunoglobulin G
Number of Launched Drugs:2
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Approved

Product Inquiry

* We couldn't find what you're looking for. You can let us help by filling the form below. Our tech team will get back to you shortly.
* This form is only used to collect product demand consultation. All the information will be kept strictly confidential.
Product inquiry collection form
*
*
*
*
*
*
*
*
*
ACRO Quality

Synonym Name

Background

ADE has been observed in SARS, MERS and other human respiratory virus infections, which suggests a real risk of ADE for SARS-CoV-2 vaccines and antibody-based interventions. Non-neutralizing mAbs against SARS-CoV-2 should be administered to determine whether non-neutralizing antibodies enhance disease.

Clinical and Translational Updates

    This web search service is supported by Google Inc.

    totopphone
    Call us
    お問い合わせ
    グローバル：+1 800-810-0816(Toll Free)
    日本：+(0)81-50-547-99099
    Email
    メールアドレス
    order.jp@acrobiosystems.com
    Fax
    ファックス
    +1 888-377-6111
    Address
    株式会社アクロバイオシステムズ
    〒157-0066
    東京都世田谷区成城1丁目26番9-101号

    アクロバイオシステムズの公式アカウント

    linkedin twitter facebook youtube

    お問い合わせ（半角英文字で入力してください）

    Copyright © 2017 ACROBiosystems. All Rights Reserved
    Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap